These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 19552103)
21. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India. Rajendran R; Sunish IP; Mani TR; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP Trop Med Int Health; 2006 Jun; 11(6):851-61. PubMed ID: 16772007 [TBL] [Abstract][Full Text] [Related]
22. Mass drug administration against lymphatic filariasis: experiences from Kozhikode district of Kerala State. Regu K; Showkath Ali MK; Rajendran R; Koya SM; Ganesh B; Dhariwal AC; Lal S J Commun Dis; 2006 Dec; 38(4):333-8. PubMed ID: 17913209 [TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of the use of vector control and mass drug administration, separately or in combination, against lymphatic filariasis. Krishnamoorthy K; Rajendran R; Sunish IP; Reuben R Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S77-90. PubMed ID: 12625921 [TBL] [Abstract][Full Text] [Related]
24. Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis. Ramaiah KD; Das PK; Vanamail P; Pani SP Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):555-63. PubMed ID: 17374389 [TBL] [Abstract][Full Text] [Related]
25. Tolerability and efficacy of a three-age class dosage schedule of Diethylcarbamazine citrate (DEC) in the treatment of microfilaria carriers of Wuchereria bancrofti and its implications in mass drug administration (MDA) strategy for elimination of lymphatic filariasis (LF). Pani SP; Das LK; Vanamail P J Commun Dis; 2005 Mar; 37(1):12-7. PubMed ID: 16637395 [TBL] [Abstract][Full Text] [Related]
26. Persistent 'hotspots' of lymphatic filariasis microfilaraemia despite 14 years of mass drug administration in Ghana. Biritwum NK; Yikpotey P; Marfo BK; Odoom S; Mensah EO; Asiedu O; Alomatu B; Hervie ET; Yeboah A; Ade S; Hinderaker SG; Reid A; Takarinda KC; Koudou B; Koroma JB Trans R Soc Trop Med Hyg; 2016 Dec; 110(12):690-695. PubMed ID: 28938053 [TBL] [Abstract][Full Text] [Related]
27. Situation analysis in a large urban area of India, prior to launching a programme of mass drug administrations to eliminate lymphatic filariasis. Ramaiah KD; Vijay Kumar KN; Ravi R; Das PK Ann Trop Med Parasitol; 2005 Apr; 99(3):243-52. PubMed ID: 15829134 [TBL] [Abstract][Full Text] [Related]
28. Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communities. Biritwum NK; Frempong KK; Verver S; Odoom S; Alomatu B; Asiedu O; Kontoroupis P; Yeboah A; Hervie ET; Marfo B; Boakye DA; de Vlas SJ; Gyapong JO; Stolk WA PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007115. PubMed ID: 31398203 [TBL] [Abstract][Full Text] [Related]
29. Predictors of compliance with a mass drug administration programme for lymphatic filariasis in Orissa State, India 2008. Cantey PT; Rao G; Rout J; Fox LM Trop Med Int Health; 2010 Feb; 15(2):224-31. PubMed ID: 20002615 [TBL] [Abstract][Full Text] [Related]
30. Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance. Babu BV; Mishra S Trans R Soc Trop Med Hyg; 2008 Dec; 102(12):1207-13. PubMed ID: 18632125 [TBL] [Abstract][Full Text] [Related]
31. Role of community empowerment in the elimination of lymphatic filariasis in south India. Rajendran R; Sunish IP; Munirathinam A; Ashok Kumar V; Tyagi BK Trop Biomed; 2010 Apr; 27(1):68-78. PubMed ID: 20562816 [TBL] [Abstract][Full Text] [Related]
32. Cost of mass annual single dose diethylcarbamazine distribution for the large scale control of lymphatic filariasis. Krishnamoorthy K; Ramu K; Srividya A; Appavoo NC; Saxena NB; Lal S; Das PK Indian J Med Res; 2000 Mar; 111():81-9. PubMed ID: 10937383 [TBL] [Abstract][Full Text] [Related]
33. Rural-urban population movement, community context and impact on DEC fortified salt program to eliminate lymphatic filariasis. Nandha B; Krishnamoorthy K J Commun Dis; 2011 Jun; 43(2):97-103. PubMed ID: 23785866 [TBL] [Abstract][Full Text] [Related]
34. Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India. Babu BV; Rath K; Kerketta AS; Swain BK; Mishra S; Kar SK Trans R Soc Trop Med Hyg; 2006 May; 100(5):464-9. PubMed ID: 16288792 [TBL] [Abstract][Full Text] [Related]
35. Knowledge and perceptions about lymphatic filariasis: a study during the programme to eliminate lymphatic filariasis in an urban community of Orissa, India. Rath K; Nath N; Shaloumy M; Swain BK; Suchismita M; Babu BV Trop Biomed; 2006 Dec; 23(2):156-62. PubMed ID: 17322817 [TBL] [Abstract][Full Text] [Related]
36. Impact of seven rounds of mass administration of diethylcarbamazine and ivermectin on prevalence of chronic lymphatic filariasis in south India. Yuvaraj J; Pani SP; Vanamail P; Ramaiah KD; Das PK Trop Med Int Health; 2008 May; 13(5):737-42. PubMed ID: 18346027 [TBL] [Abstract][Full Text] [Related]
37. Clinicians' attitude on mass drug administration under the program to eliminate lymphatic filariasis: a qualitative study from Orissa, India. Kerketta AS; Babu BV Asia Pac J Public Health; 2009 Jan; 21(1):112-7. PubMed ID: 19124342 [TBL] [Abstract][Full Text] [Related]
38. Clinicians' practices related to management of filarial adenolymphangitis and lymphoedema in Orissa, India. Kerketta AS; Babu BV; Swain BK Acta Trop; 2007 Jun; 102(3):159-64. PubMed ID: 17553441 [TBL] [Abstract][Full Text] [Related]